
Glycated Albumin Improves Prediction of Adverse CKD Outcomes
Adding glycated albumin to HbA1c may improve glycemic monitoring and risk stratification in patients with chronic kidney disease (CKD) according to research presented at the American Society of Nephrology’s Kidney Week 2023 meeting. The study measured baseline serum glycated albumin levels in 3110 CKD patients and found that higher levels were associated with increased risks…